ABSTRACT
Epigenetic changes are potentially important for the ontogeny and progression of tumors but are not usually studied because of the complexity of analyzing transcript regulation resulting from epigenetic alterations. Prostate cancer (PCa) is characterized by variable clinical manifestations and frequently unpredictable outcomes. We performed an expression quantitative trait loci (eQTL) analysis to identify the genomic regions that regulate gene expression in PCa and identified a relationship between DNA methylation and clinical information. Using multi-level information published in The Cancer Genome Atlas, we performed eQTL-based analyses on DNA methylation and gene expression. To better interpret these data, we correlated loci and clinical indexes to identify the important loci for both PCa development and progression. Our data demonstrated that although only a small proportion of genes are regulated via DNA methylation in PCa, these genes are enriched in important cancer-related groups. In addition, single nucleotide polymorphism analysis identified the locations of CpG sites and genes within at-risk loci, including the 19q13.2-q13.43 and 16q22.2-q23.1 loci. Further, an epigenetic association study of clinical indexes detected risk loci and pyrosequencing for site validation. Although DNA methylation-regulated genes across PCa samples are a small proportion, the associated genes play important roles in PCa carcinogenesis.
Subject(s)
DNA Methylation/genetics , Prostatic Neoplasms/genetics , Aged , Gene Regulatory Networks/genetics , Genome-Wide Association Study/methods , Genome-Wide Association Study/statistics & numerical data , Humans , Male , Middle Aged , Prostatic Neoplasms/etiologyABSTRACT
BACKGROUND: This study aims to identify the association between microRNA 25 (mRNA 25) expression in serum and lung cancer (LC). METHODS: This planned study will cover all eligible case-controlled studies that report association between mRNA 25 expression in serum and LC. It will include published studies from inception to the present in Cochrane Library, PUBMED, EMBASE, Web of Science, Allied and Complementary Medicine Database, VIP database, and China National Knowledge Infrastructure regardless language and geographical location. We will also search other sources, such as conference abstracts and reference lists of related known studies and experts in the domain consulted to avoid missing potential studies. Two contributors will independently examine and select studies, collect all necessary data, and judge study quality for all included studies. We will perform statistical analysis using RevMan V.5.3 software and Stata V.12.0 software. RESULTS: This study will summarize current evidence to present first systematic review of research on the association between mRNA 25 expression in serum and LC. CONCLUSION: This study will present comprehensive evidence to determine whether mRNA 25 expression in serum is associated with LC, and will provide helpful evidence for the future studies. SYSTEMATIC REVIEW REGISTRATION: INPLASY202040056.
Subject(s)
Lung Neoplasms/blood , MicroRNAs/blood , Biomarkers, Tumor , Case-Control Studies , Early Detection of Cancer , Humans , MicroRNAs/biosynthesis , Research Design , Meta-Analysis as TopicABSTRACT
Various forms of noninvasive respiratory support have been applied to the treatment of infant respiratory distress and hypoxemia.The most common noninvasive respiratory support in neonatal intensive care unit is nasal continuous positive airway pressure (NCPAP).But the NCPAP systems are not always well accepted by the neonatal population,with the risk of mucosal injury and nosocomial infection.In recent years,humidified high-flow nasal cannula (HHFNC) has been introduced and developed as a possible alternative to NCPAP for noninvasive respiratory support mode,because it increases patients' comfort and the effectiveness of the ventilation.This article summarized the current research progress of HHFNC therapy in pediatric patients.
ABSTRACT
Various forms of noninvasive respiratory support have been applied to the treatment of infant respiratory distress and hypoxemia. The most common noninvasive respiratory support in neonatal intensive care unit is nasal continuous positive airway pressure (NCPAP). But the NCPAP systems are not always well accepted by the neonatal population, with the risk of mucosal injury and nosocomial infection. In recent years, humidified high-flow nasal cannula (HHFNC) has been introduced and developed as a possible alternative to NCPAP for noninvasive respiratory support mode, because it increases patients' comfort and the effectiveness of the ventilation. This article summarized the current research progress of HHFNC therapy in pediatric patients.
